Positive association between APOA5 rs662799 polymorphism and coronary heart disease: A case-control study and meta-analysis

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Ye, Huadan ^a   Zhou, Annan ^a   Hong, Qiangxiao ^a   Tang, Linlin ^a   Xu, Xuting ^a   Xin, Yanfei ^b   Jiang, Danjie ^a   Dai, Dongjun ^a   Li, Yirun ^a   Wang, Dao Wen ^c   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5; GENOMIC DNA; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; APOA5 GENE; ARTICLE; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAN CHINESE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

APOLIPOPROTEIN A-V; APOLIPOPROTEINS A; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEX FACTORS; TRIGLYCERIDES;

EID: 84943182268     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135683     Document Type: Article

References (84)

1. Chen Q, Reis SE, Kammerer C, Craig W, McNamara DM, Holubkov R, et al. (2011) Association of antioxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study. J Lipid Res 52(4): 801-807. doi: 10.1194/jlr.M012963 PMID: 21252261
2. Huang Y, Lian J, Huang RS, Wang F, Xu L, Le Y, et al. (2013) Positive association between rs10918859 of the NOS1AP gene and coronary heart disease in male Han Chinese. Genet Test Mol Biomarkers 17(1): 25-29. doi: 10.1089/gtmb.2012.0254 PMID: 23171141
3. Zhang X, Lu Z, Liu L. (2008) Coronary heart disease in China. Heart 94(9): 1126-1131. doi: 10.1136/hrt.2007.132423 PMID: 18703693
4. Zhou J, Huang Y, Huang RS, Wang F, Xu L, Le Y, et al. (2012) A case-control study provides evidence of association for a common SNP rs974819 in PDGFD to coronary heart disease and suggests a sexdependent effect. Thromb Res 130(4): 602-606. doi: 10.1016/j.thromres.2012.05.023 PMID: 22704460
5. De Andrade FM, Maluf SW, Schuch JB, Voigt F, Barros AC, Lucatelli JF, et al. (2011) The influence of the S19W SNP of the APOA5 gene on triglyceride levels in southern Brazil: Interactions with the APOE gene, sex and menopause status. Nutr Metab Cardiovasc Dis 21(8): 584-590. doi: 10.1016/j.numecd. 2009.12.013 PMID: 20304614
6. Waterworth DM, Ricketts SL, Song K, Chen L, Zhao J, Ripatti S, et al. (2010) Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 30(11): 2264-2276. doi: 10.1161/ATVBAHA.109.201020 PMID: 20864672
7. Zhao Y. (2012) To evaluate the effect of TFPI/FoxO in the incidence of CHD among North pupulation. China people's Liberation Army Medical Institute.
8. Hubacek JA, Adamkova V, Vrablik M, Kadlecova M, Zicha J, Kunes J, et al. (2009) Apolipoprotein A5 in health and disease. Physiol Res 58(Suppl 2): S101-109. PMID: 20131928
9. Hadarits F, Kisfali P, Mohas M, Maasz A, Duga B, Janicsek I, et al. (2012) Common functional variants of APOA5 and GCKR accumulate gradually in association with triglyceride increase in metabolic syndrome patients. Mol Biol Rep 39(2): 1949-1955. doi: 10.1007/s11033-011-0942-8 PMID: 21643755
10. Yang Y, Walijee SM, Jin J, Zhao S, Peng D. (2012) Serum apolipoprotein A-V in patients with coronary artery disease and its association with triglyceride. J Clin Lipidol 6(5): 462-468. doi: 10.1016/j.jacl. 2012.02.004 PMID: 23009782
11. Park JY, Paik JK, Kim OY, Chae JS, Jang Y, Lee JH. (2010) Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on omega6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease. J Lipid Res 51(11): 3281-3288. doi: 10.1194/jlr.M010330 PMID: 20802161
12. Saleheen D, Soranzo N, Rasheed A, Scharnagl H, Gwilliam R, Alexander M, et al. (2010) Genetic determinants of major blood lipids in Pakistanis compared with Europeans. Circ Cardiovasc Genet 3 (4): 348-357. doi: 10.1161/CIRCGENETICS.109.906180 PMID: 20570915
13. De Caterina R, Talmud PJ, Merlini PA, Foco L, Pastorino R, Altshuler D, et al. (2011) Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction. Atherosclerosis 214 (2): 397-403. doi: 10.1016/j.atherosclerosis.2010.11.011 PMID: 21130994
14. Vu-Dac N, Gervois P, Jakel H, Nowak M, Bauge E, Dehondt H, et al. (2003) Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators. J Biol Chem 278(20): 17982-17985. PMID: 12637506
15. Kisfali P, Mohas M, Maasz A, Polgar N, Hadarits F, Marko L, et al. (2010) Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis 20(7): 505-511. doi: 10.1016/j.numecd.2009.05.001 PMID: 19692219
16. Laurila PP, Naukkarinen J, Kristiansson K, Ripatti S, Kauttu T, Silander K, et al. (2010) Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis. Arterioscler Thromb Vasc Biol 30(2): 346-352. doi: 10.1161/ATVBAHA.109.188912 PMID: 19910639
17. Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY, Choi JR, et al. (2009) The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: Association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin Chim Acta 402(1-2): 83-87. doi: 10.1016/j. cca.2008.12.024 PMID: 19159622
18. Seda O, Sedova L. (2003) New apolipoprotein A-V: Comparative genomics meets metabolism. Physiol Res 52(2): 141-146. PMID: 12678656
19. Li X, Gong H, Huang X, Huang W, Zhao S. (2013) The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndrome. Lipids Health Dis 12: 133. doi: 10.1186/1476-511X-12-133 PMID: 24016248
20. Ding Y, Zhu M, Wang Z, Zhu J, Feng J, Li D. (2012) Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome. J Biomed Biotechnol 2012: 509420. doi: 10.1155/2012/509420 PMID: 22675253
21. Ramakrishnan L, Sachdev HS, Sharma M, Abraham R, Prakash S, Gupta D, et al. (2011) Relationship of APOA5, PPARgamma and HL gene variants with serial changes in childhood body mass index and coronary artery disease risk factors in young adulthood. Lipids Health Dis 10: 68. doi: 10.1186/1476-511X-10-68 PMID: 21548985
22. Takeuchi F, Isono M, Katsuya T, Yokota M, Yamamoto K, Nabika T, et al. (2012) Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals. PLoS One 7(9): E46385. doi: 10.1371/journal.pone.0046385 PMID: 23050023
23. Zhou J, Xu L, Huang RS, Huang Y, Le Y, Jiang D, et al. (2013) Apolipoprotein A5 gene variants and the risk of coronary heart disease: A case-control study and meta-analysis. Mol Med Rep 8(4): 1175-1182. doi: 10.3892/mmr.2013.1642 PMID: 23970179
24. Huang Y, Zhou J, Ye H, Xu L, Le Y, Yang X, et al. (2013) Relationship between chemokine (C-X-C motif) ligand 12 gene variant (rs1746048) and coronary heart disease: Case-control study and metaanalysis. Gene 521(1): 38-44. doi: 10.1016/j.gene.2013.02.047 PMID: 23531450
25. Lian J, Huang Y, Huang RS, Xu L, Le Y, Yang X, et al. (2013) Meta-analyses of four eosinophil related gene variants in coronary heart disease[J]. J Thromb Thrombolysis 36(4): 394-401. doi: 10.1007/s11239-012-0862-z PMID: 23328882
26. Xu L, Zhou J, Huang S, Huang Y, Le Y, Jiang D, et al. (2013) An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A(2) and coronary heart disease[J]. Exp Ther Med 5(3): 742-750. PMID: 23404648
27. Zhang L, Liu P, Zhou J, Huang RS, Yuan F, Fei L, et al. (2013) Positive correlation between variants of lipid metabolismrelated genes and coronary heart disease. Mol Med Rep 8(1): 260-266. doi: 10.3892/mmr.2013.1454 PMID: 23653095
28. Gabriel S, Ziaugra L, Tabbaa D. (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet Chapter 2: Unit 2 12.
29. Glatt SJ, Faraone SV, Tsuang MT. (2003) Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: Meta-analysis of case-control and family-based studies. Am J Psychiatry 160(3): 469-476. PMID: 12611827
30. -(2007) Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447(7145): 661-678. PMID: 17554300
31. Song D, Guo J, Kang W, Guo X, Zhang Q. (2007) Apolipoprotein gene mutation test and clinical application in Coronary heart disease. Chin J Lab Med 30(1): 65-66.
32. He J, Gou Z, Dai J, Sun H. (2012) Association Study on Apolipoprotein A5 Gene Polymorphism and Serum Lipid Metabolism and Coronary Heart Disease. J Mod Lab Med 27(2): 15-18.
33. Yang F, Yang Z, Wang L. (2007) Association of APOA5 gene -1131T/C single nucleotide polymorphism with coronary heart disease among Chinese Han population. Shandong Medicine 47(19): 1-3.
34. Han T. (2011) A Study on the Haplotype of Apolipoprotein A5/C3 Gene Cluster and Correlation to the Patients with Coronary Artery Disease in Shandong Coastal Area. shandong University Press, JiNan.
35. Wang C. (2002) Polymorphism in the apoliprotein A5 gene and their association with coronary heart disease in Chinese. Fujian Medical University Press, FuZhou.
36. Dai H, Ye G, Shi Z, Zhao Y. (2013) Relationship of APOA5 Level and APOA5 -1131T/C Locus Genen Polymorphism to Early-oneset CHD and Restenoses after Percutaneous Coronary Intervention in Han population. Chinese General Pratics 16(11B): 3821-3824.
37. Zhang C. (2009) The associations between Uygu-Han APOA5, APOB, CETPgene and liPids of coronary heart disease with diabetes. Xinjiang Medical University Press, Wulumuqi.
38. Zhang X, Liu T, Cai W, Yan C, Liang Z, Sun Y, et al. (2012) Association of Apolipoprotein T-1131C with Acute Coronary Syndrome in Han Population of North China. Progress in Modern Biomedicine 12(8): 1401-1404.
39. Cheng X, Yan S, Song Y, Xiao X, Bi N, Chen B. (2007) Relationship between Apolipoprotein AV gene -1131T/C polymorphism and Type 2 Diabates Mellitus with Coronary Heart Disease in Han Nationality. Molecular Cardiology of China 7(4): 189-194.
40. Li X, Zhao S, Nie S. (2007) Relationship Between Apolipoprotein A5 -1131T>C Polymorphism and Coronary Heart Disease. Chinese Circulation Journal 22(1): 4-8.
41. Zhu M, Zhou Y, Ding Y, Mao D. (2007) Apolipoprotein A5 gene-1131-t > C polymorphism in Coronary Heart Disease Patient. Chinese Journal of gerontology 27(1): 73-75.
42. Bi N, Yan S, Li G, Yin Z, Chen B. (2004) A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. Mol Genet Metab 83(3): 280-286. PMID: 15542401
43. Hubacek JA, Skodova Z, Adamkova V, Lanska V, Poledne R (2004) The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 65(2): 126-130. PMID: 14984471
44. Szalai C, Keszei M, Duba J, Prohaszka Z, Kozma GT, Csaszar A, et al. (2004) Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 173(1): 109-114. PMID: 15177130
45. Liu H, Zhang S, Lin J, Li H, Huang A, Xiao C, et al. (2005) Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism 54(5): 568-572. PMID: 15877284
46. Hsu LA, Ko YL, Chang C, Hu CF, Wu S, Teng MS, et al. (2006) Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 185(1): 143-149. PMID: 16054149
47. Tang Y, Sun P, Guo DP, Li X, Chen Q, Fan L, et al. (2005) Association between apolipoprotein A5-1131T > C polymorphism and susceptibility of coronary artery disease in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22(3): 281-283. PMID: 15952115
48. Yan S, Cheng X, Song Y, Xiao X, Bi N, Chen B et al. (2005) Apolipoprotein A5 gene polymorphism -1131T→C: Association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese. Clin Chem Lab Med 43(6): 607-612. PMID: 16006256
49. Ruiz-Narvaez EA, Yang Y, Nakanishi Y, Kirchdorfer J, Campos H (2005) APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica. J Lipid Res 46(12): 2605-2613. PMID: 16192625
50. Havasi V, Szolnoki Z, Talian G, Bene J, Komlosi K, Maasz A, et al. (2006) Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke. J Mol Neurosci 29(2): 177-183. PMID: 16954607
51. Vaessen SF, Schaap FG, Kuivenhoven JA, Groen AK, Hutten BA, Boekholdt SM, et al. (2006) Apolipoprotein A-V, triglycerides and risk of coronary artery disease: The prospective Epic-Norfolk Population Study. J Lipid Res 47(9): 2064-2070. PMID: 16769999
52. Yu Y, Xue L, Zhao C. (2007) Study on polymorphism in the apolipoprotein A5 gene in patients with premature coronary heart disease. Beijing Da Xue Xue Bao 39(6): 576-580. PMID: 18087544
53. Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, et al. (2007) The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: An angiographic study. Atherosclerosis 191(2): 409-417. PMID: 16682041
54. Maasz A, Kisfali P, Jaromi L, Horvatovich K, Szolnoki Z, Csongei V, et al. (2008) Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke. Circ J 72 (7): 1065-1070. PMID: 18577813
55. AshokKumar M, Subhashini NG, SaiBabu R, Ramesh A, Cherian KM, Emmanuel C. (2010) Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians. Mol Biol Rep 37(1): 521-527. doi: 10.1007/s11033-009-9728-7 PMID: 19701693
56. Prochaska CL, Picheth G, Anghebem-Oliveira MI, Costantini CO, de Souza EM, Pedrosa FO, et al. (2010) The polymorphisms -1131T>C and the S19W of the APOA5 gene are not associated with coronary artery disease in a Brazilian population. Clin Chem Lab Med 48(3): 419-422. doi: 10.1515/CCLM. 2010.070 PMID: 20170397
57. Bhanushali AA, Das BR (2010) Influence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians. J Community Genet 1 (3): 139-148. doi: 10.1007/s12687-010-0025-x PMID: 22460246
58. Bhaskar S, Ganesan M, Chandak GR, Mani R, Idris MM, Khaja N, et al. (2011) Association of PON1 and APOA5 gene polymorphisms in a cohort of Indian patients having coronary artery disease with and without type 2 diabetes. Genet Test Mol Biomarkers 15(7-8): 507-512. doi: 10.1089/gtmb.2010.0207 PMID: 21438666
59. Qiu F. (2007) The association of polymorphisms in apolipopro-teina 5 gene with blood lipids and heart cerebrovascular disease. Southeast University Press, Nanjing.
60. Zhang Y. (2007) Associations of apoA5 polymorphisms, blood lipids and coronary heart disease in the Chinese. Zhejiang University Press, Hangzhou.
61. Xu L, He T. (2008) Correlation of apolipoprotein A5 SNP3 gene single nucleotide polymorphism with coronary artery disease in Chinese. Shandong Med J 48(46): 1-3.
62. Zhao L. (2008) Association between apolipoprotein A5 -1131T>C polymorphism and coronary heart disease in xinjiang Uygur. Xinjiang Medical University Press, Wulumuqi.
63. Chen Y, Xu L, Zhang J, Li R. (2011) Study on the relationship between apolipoprotein A5 gene polymorphism and coronary artery disease. Chin J Conval Med 20(6): 487-489.
64. Excoffier L, Lischer HE (2010) Arlequin suite ver 3.5: A new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 10(3): 564-567. doi: 10.1111/j.1755-0998.2010.02847.x PMID: 21565059
65. Sham PC, Curtis D (1995) Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59(Pt 1): 97-105.
66. Ye H, Li X, Wang L, Liao Q, Xu L, Huang Y, et al. (2013) Genetic associations with coronary heart disease: Meta-analyses of 12 candidate genetic variants. Gene 531(1): 71-77. doi: 10.1016/j.gene.2013. 07.029 PMID: 23906684
67. Rafiq S, Venkata KK, Gupta V, Vinay DG, Spurgeon CJ, Parameshwaran S, et al. (2012) Evaluation of seven common lipid associated loci in a large Indian sib pair study. Lipids Health Dis 11: 155. doi: 10. 1186/1476-511X-11-155 PMID: 23150898
68. Mendelsohn ME, Karas RH (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308 (5728): 1583-1587. PMID: 15947175
69. Ober C, Loisel DA, Gilad Y (2008) Sex-specific genetic architecture of human disease. Nat Rev Genet 9 (12): 911-922. doi: 10.1038/nrg2415 PMID: 19002143
70. Rai M, Baker WL, Parker MW, Heller GV (2012) Meta-analysis of optimal risk stratification in patients >65 years of age. Am J Cardiol 110 (8): 1092-1099. doi: 10.1016/j.amjcard.2012.05.048 PMID: 22795509
71. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. (2011) Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation 123 (4): E18-e209.
72. Shi K, Wu F, Liu W, Zhao C, Chen C, Xie Y, et al. (2014) Non-alcoholic fatty liver disease and risk of instent restenosis after bare metal stenting in native coronary arteries. Mol Biol Rep 41(7): 4713-4720. doi: 10.1007/s11033-014-3342-z PMID: 24691745
73. Post WS, Budoff M, Kingsley L, Palella FJ Jr., Witt MD, Li X, et al. (2014) Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med 160(7): 458-467. doi: 10.7326/M13-1754 PMID: 24687069
74. Fernandez R, Rolley JX, Rajaratnam R, Sundar S, Patel NC, Davidson PM. (2014) Risk Factors for Coronary Heart Disease Among Asian Indians Living in Australia. J Transcult Nurs.
75. Ginter E, Simko V (2013) Women live longer than men. Bratisl Lek Listy 114(2): 45-49. PMID: 23331196
76. Dallongeville J, Cottel D, Montaye M, Codron V, Amouyel P, Helbecque N. (2006) Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int J Cardiol 106(2): 152-156. PMID: 16321685
77. Maasz A, Kisfali P, Szolnoki Z, Hadarits F, Melegh B (2008) Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke. J Neurol 255 (5): 649-654. doi: 10.1007/s00415-008-0768-z PMID: 18274806
78. Yuan S, Ma Y, Xie X, Yang Y, Fu Z, Ma X, et al. (2011) [Association of apolipoprotein A5 gene polymorphism with coronary heart disease in Uygur population of Xinjiang]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 28 (1): 73-77. doi: 10.3760/cma.j.issn.1003-9406.2011.01.017 PMID: 21287515
79. Angelakopoulou A, Shah T, Sofat R, Shah S, Berry DJ, Cooper J, et al. (2012) Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration. Eur Heart J 33 (3): 393-407. doi: 10.1093/eurheartj/ehr225 PMID: 21804106
80. Yu H, Shi J. (2011) APOA5 polymorphism and coronary heart disease in Han Chinese: A meta-analysis. Chin J Public Health 27(9): 1195-1196.
81. Zhai G, Li M, Zhu C. (2011) APOA5 -1131T/C polymorphism is associated with coronary artery disease in a Chinese population: A meta-analysis. Clin Chem Lab Med 49(3): 535-539. doi: 10.1515/CCLM. 2011.070 PMID: 21143013
82. Li Y, Wu X, Xu J, Qian Y, Zhou C, Wang B, et al. (2013) Apo A5 -1131T/C, FgB -455G/A, -148C/T, and CETP TaqIB gene polymorphisms and coronary artery disease in the Chinese population: A meta-analysis of 15, 055 subjects. Mol Biol Rep 40(2): 1997-2014. doi: 10.1007/s11033-012-2257-9 PMID: 23129316
83. Zhang Z, Peng B, Gong R, Gao L, Du J, Fang D, et al. (2011) Apolipoprotein A5 polymorphisms and risk of coronary artery disease: A meta-analysis. Biosci Trends 5(4): 165-172. doi: 10.5582/bst.2011. v5.4.165 PMID: 21914952
84. Pan Z, Trikalinos TA, Kavvoura FK, Lau J, Ioannidis JP (2005) Local literature bias in genetic epidemiology: An empirical evaluation of the Chinese literature. PLoS Med 2 (12): E334. PMID: 16285839